Trial of Oxford’s promising COVID vaccine resumes after brief pause

Read MoreHuge global trial was halted after a single participant showed a possible adverse reaction, but the U.K.’s independent safety regulator cleared it to resume.Huge global trial was halted after a single participant showed a possible adverse reaction, but the U.K.’s independent safety regulator cleared it to resume.